← All trials
NCT04549610
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2019
- Primary completion
- May 1, 2021
- Completion date
- Jul 1, 2021
- First posted
- Sep 16, 2020
- Last posted
- Sep 16, 2020
- Enrollment
- 30
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Poznan UniversityLead sponsor
- Poznan UniversityReponsible party - principal investigator
- National Science Centre, PolandCollaborator
- Poznan UniversityCollaborator
- University of Sao PauloStudy chair
- Poznan UniversityOverall official - principal investigator
- University of Sao PauloCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.